Last update 01 Nov 2024

Amidohydrolases x CYP2E1

Basic Info

Related Targets
AmidohydrolasesCYP2E1

Related

1
Drugs associated with Amidohydrolases x CYP2E1
HUEXC-030
Target
Amidohydrolases x CYP2E1
Mechanism
Amidohydrolases inhibitors [+1]
Active Org.-
Originator Org.
Orient Pharma Co., Ltd.Orient Pharma Co., Ltd.
Active Indication-
Inactive Indication
Tuberculosis
Drug Highest PhaseSuspended
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with Amidohydrolases x CYP2E1
Login to view more data
100 Translational Medicine associated with Amidohydrolases x CYP2E1
Login to view more data
0 Patents (Medical) associated with Amidohydrolases x CYP2E1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free